Georg Peters

30.6k total citations · 8 hit papers
332 papers, 22.9k citations indexed

About

Georg Peters is a scholar working on Infectious Diseases, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, Georg Peters has authored 332 papers receiving a total of 22.9k indexed citations (citations by other indexed papers that have themselves been cited), including 205 papers in Infectious Diseases, 139 papers in Molecular Biology and 69 papers in Clinical Biochemistry. Recurrent topics in Georg Peters's work include Antimicrobial Resistance in Staphylococcus (194 papers), Bacterial biofilms and quorum sensing (97 papers) and Bacterial Identification and Susceptibility Testing (68 papers). Georg Peters is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (194 papers), Bacterial biofilms and quorum sensing (97 papers) and Bacterial Identification and Susceptibility Testing (68 papers). Georg Peters collaborates with scholars based in Germany, United States and Netherlands. Georg Peters's co-authors include Karsten Becker, Christof von Eiff, Christine Heilmann, Richard A. Proctor, Muzaffar Hussain, Barbara C. Kahl, Mathias Herrmann, K. Machka, Holger Stammer and Mathias Herrmann and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Georg Peters

326 papers receiving 22.2k citations

Hit Papers

Nasal Carriage as a Source ofStaphylococcus aureusBacteremia 1988 2026 2000 2013 2001 2014 2006 2002 2011 500 1000 1.5k

Peers

Georg Peters
Comparison fields: 5 of 180
  • Infectious Diseases 13.6k
  • Molecular Biology 11.1k
  • Clinical Biochemistry 4.4k
  • Epidemiology 3.7k
  • Public Health, Environmental and Occupational Health 2.6k
Replace Alex van Belkum with:
Alex van Belkum Netherlands
Henri A. Verbrugh Netherlands
François Vandenesch France
Gérard Lina France
Jacques Schrenzel Switzerland
David H. Persing United States
Patrice François Switzerland
Frank R. DeLeo United States
Arnold S. Bayer United States
Michaël Otto United States
Alex van Belkum Netherlands View profile →
Citations per field, relative to Georg Peters
Georg Peters · 1×
Citations per year, relative to Georg Peters
Georg Peters · 1×

Countries citing papers authored by Georg Peters

Since Specialization
Citations

This map shows the geographic impact of Georg Peters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg Peters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg Peters more than expected).

Fields of papers citing papers by Georg Peters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georg Peters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg Peters. The network helps show where Georg Peters may publish in the future.

Co-authorship network of co-authors of Georg Peters

This figure shows the co-authorship network connecting the top 25 collaborators of Georg Peters. A scholar is included among the top collaborators of Georg Peters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georg Peters. Georg Peters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 5
2 38
3 36
4 39
5 130
6 9
7 45
8 13
9 5
10
Methicillin-resistant Staphylococcus aureus (MRSA)
4
11 32
12 87
13 42
14 17
15
Final analysis of a randomized study on the value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high risk myelodysplastic syndromes and elderly AML
2
16 102
17
A randomized study on the value of Fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high risk myelodysplastic syndromes and elderly AML. A report from the Dutch-Belgian hemato-oncology cooperative group (HOVON)
2
18 12
19 69
20 40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026